Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced-dose onabotuLinumtoxinA for Urgency Incontinence Among Elder Females (RELIEF): A Randomized Controlled Comparative Effectiveness Trial With Embedded Qualitative and Costing Analyses

NCT05512039 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT05512039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05512039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced-dose onabotuLinumtoxinA for Urgency Incontinence Among Elder Females (RELIEF): A Randomized Controlled Comparative Effectiveness Trial With Embedded Qualitative and Costing Analyses
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 12, 2023
Completion date
January 1, 2027
Enrollment
376 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urgency urinary incontinence, urinary incontinence in old age